Alejandro Castro is a seasoned finance professional with extensive experience in gross to net finance, financial planning and analysis (FP&A), and strategic business support across multiple sectors, including pharmaceuticals and telecommunications. Currently serving as Director of Gross to Net Finance at Jazz Pharmaceuticals since July 2023, Alejandro collaborates with various cross-functional teams to enhance transparency and insights related to financial performance. Prior roles include Vice President of Finance FP&A at McKesson, where tactical market insights informed financial recommendations, and Senior Director of Gross to Net Forecasting at Teva Pharmaceuticals, overseeing deductions and forecasting deliverables for a significant branded portfolio. Alejandro's earlier career includes key positions at Sprint and Citi, where responsibilities encompassed financial analysis, budgeting, and operational support. Alejandro holds an MBA in Finance from Wichita State University and a Bachelor of Engineering in Industrial Engineering from Universidad Nacional de Colombia.